BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · IEX Real-Time Price · USD

1.170

-0.070 (-5.65%)

At close: Jul 19, 2024, 4:00 PM

1.190

+0.020 (1.71%)

Pre-market: Jul 22, 2024, 7:47 AM EDT

BioXcel Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2016
Revenue	1.76	1.38	0.38	0	0	0	Upgrade
Revenue Growth (YoY)	202.24%	268.00%	-	-	-	-	Upgrade
Cost of Revenue	1.33	1.26	0.02	0	0	0	Upgrade
Gross Profit	0.42	0.12	0.36	0	0	0	Upgrade
Selling, General & Admin	73.08	83.41	68.76	54.23	24.3	7.8	Upgrade
Research & Development	67.93	84.33	91.24	52.71	58	25.8	Upgrade
Other Operating Expenses	4.16	4.16	0	0	0	0	Upgrade
Operating Expenses	145.17	171.9	160	106.94	82.3	33.6	Upgrade
Operating Income	-144.75	-171.78	-159.65	-106.94	-82.3	-33.6	Upgrade
Interest Expense / Income	13.55	13.31	8.21	0.04	0.03	0.02	Upgrade
Other Expense / Income	-5.25	-6.04	-2.1	-0.04	-0.16	-0.65	Upgrade
Pretax Income	-153.05	-179.05	-165.76	-106.93	-82.17	-32.97	Upgrade
Net Income	-153.05	-179.05	-165.76	-106.93	-82.17	-32.97	Upgrade
Shares Outstanding (Basic)	31	29	28	26	22	16	Upgrade
Shares Outstanding (Diluted)	31	29	28	26	22	16	Upgrade
Shares Change	7.87%	3.98%	6.23%	21.63%	33.11%	11.79%	Upgrade
EPS (Basic)	-5.17	-6.15	-5.92	-4.05	-3.79	-2.02	Upgrade
EPS (Diluted)	-5.17	-6.15	-5.92	-4.05	-3.79	-2.02	Upgrade
Free Cash Flow	-120.38	-155.03	-135.48	-82.6	-66.67	-27.97	Upgrade
Free Cash Flow Per Share	-3.90	-5.32	-4.84	-3.13	-3.08	-1.72	Upgrade
Gross Margin	24.15%	8.70%	94.67%	-	-	-	Upgrade
Operating Margin	-8243.11%	-12447.97%	-42572.00%	-	-	-	Upgrade
Profit Margin	-8715.72%	-12974.86%	-44201.87%	-	-	-	Upgrade
Free Cash Flow Margin	-6855.30%	-11233.77%	-36128.00%	-	-	-	Upgrade
EBITDA	-139.18	-165.42	-157.22	-106.59	-81.95	-32.79	Upgrade
EBITDA Margin	-7925.91%	-11987.03%	-41924.53%	-	-	-	Upgrade
Depreciation & Amortization	0.32	0.32	0.33	0.3	0.19	0.16	Upgrade
EBIT	-139.5	-165.74	-157.54	-106.89	-82.14	-32.95	Upgrade
EBIT Margin	-7943.91%	-12010.07%	-42011.73%	-	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).